Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURM

Eli Lilly · Phase 3 · Recruiting · Enrollment 150

NCT07817875

ArmPopulationDoseWeeksEstimandWeight change
TirzepatideObesity or overweightn/r104n/rn/r
PlaceboObesity or overweightn/r104n/rn/r